Interstitial lung disease independently associated with higher risk for COVID-19 severity and mortality: A meta-analysis of adjusted effect estimates.

Wang, Ying; Hao, Yuqing; Hu, Mengke; Wang, Yadong; Yang, Haiyan

Wang, Ying; Hao, Yuqing; Hu, Mengke; Wang, Yadong; Yang, Haiyan.

Afiliación

Wang Y; Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001, China.
Hao Y; International College of Zhengzhou University, Zhengzhou 450052, China.
Hu M; Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001, China.
Wang Y; Department of Toxicology, Henan Center for Disease Control and Prevention, Zhengzhou 450016, China.
Yang H; Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001, China. Electronic address: yhy@zzu.edu.cn.

Int Immunopharmacol ; 111: 109088, 2022 Oct.

Article en En | MEDLINE | ID: mdl-35921779

Asunto(s)

COVID-19; Enfermedades Pulmonares Intersticiales; Humanos; Masculino; Sesgo de Publicación

Palabras clave

COVID-19; Interstitial lung disease; Meta-analysis; Severity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Pulmonares Intersticiales / COVID-19 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans / Male Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google